Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BY 4.0Alzheimer's & Dementia

Developing the World‐Wide FINGERS biorepository for dementia risk reduction trials

31 more authors
40 affiliations
  1. 1FINGERS Brain Health Institute Stockholm Sweden
  2. 2Division of Neurogeriatrics, Center for Alzheimer Research, Department of Neurobiology Care Sciences and Society, Karolinska Institutet Solna Stockholm Sweden
  3. 3Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology Care Sciences and Society, Karolinska Institutet Huddinge Stockholm Sweden
  4. 4Ageing Epidemiology Research Unit, School of Public Health Imperial College London London UK
  5. 5Department of Epidemiology and Prevention Wake Forest University School of Medicine Winston Salem North Carolina USA
  6. 6Brain and Mind Institute Aga Khan University Nairobi Kenya
  7. 7Brain Imaging Centre HUN‐REN Research Centre for Natural Sciences Budapest Hungary
  8. 8Department of Neurology Clínica Universidad de Navarra Pamplona Navarra Spain
  9. 9Centre for Age‐Related Medicine (SESAM) Stavanger University Hospital Stavanger Norway
  10. 10Behavioral and Cognitive Neurology Unit, Faculdade de Medicina Universidade Federal de Minas Gerais Belo Horizonte Brazil
  11. 11Center for Research and Memory Clinic CITA‐alzheimer Foundation Donostia‐San Sebastian Spain
  12. 12Barcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain
  13. 13Hospital del Mar Research Institute Barcelona Spain
  14. 14School of Medicine and Surgery and Milan Center for Neuroscience (NeuroMI) University of Milano‐Bicocca Milano Italy
  15. 15Fondazione IRCCS San Gerardo dei Tintori Monza Italy
  16. 16Deutsches Institut für Demenz Prävention (DIDP) Medical Faculty Saarland University Homburg Germany
  17. 17Department of Experimental Neurology Saarland University Homburg Germany
  18. 18UNSW Ageing Futures Institute University of New South Wales Sydney Australia
  19. 19School of Psychology University of New South Wales Sydney Australia
  20. 20Brain Health and Dementia Centre Neuroscience Research Australia Sydney Australia
  21. 21Department of Psychiatry, School of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA
  22. 22Alzheimer's Disease Research Center University of Pittsburgh Pittsburgh Pennsylvania USA
  23. 23Unit for Brain Aging and Dementia, Department of Geriatric Medicine Dokuz Eylul University, School of Medicine Izmir Turkey
  24. 24Transversal Translational Medicine, Luxembourg Institute of Health (LIH) Strassen Luxembourg
  25. 25Luxembourg Research Clinic Centre Hospitalier de Luxembourg Luxembourg Luxembourg
  26. 26Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB) University of Luxembourg Belvaux Luxembourg
  27. 27Department of Neurology, School of Medicine, College of Medicine Taipei Medical University Taipei City Taiwan
  28. 28Department of Pharmacology, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore
  29. 29Memory, Aging and Cognition Center National University Health Systems Singapore Singapore
  30. 30Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine University of New South Wales Sydney Australia
  31. 31Alzheimer's Association Chicago Illinois USA
  32. 32Neurology Unit, Department of Medicine, Faculty of Clinical Sciences, College of Medicine University of Lagos Lagos, Lagos State Nigeria
  33. 33Centre for Healthy Aging and Wellness Faculty of Health Science Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia
  34. 34Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health Universidade Católica Portuguesa Lisbon Portugal
  35. 35Department of Public Health, Lifestyles and Living Environments Finnish Institute for Health and Welfare Helsinki Finland
  36. 36Institute of Clinical Medicine, Department of Neurology University of Eastern Finland Kuopio Finland
  37. 37National Institute of Neurology and Neurosurgery Manuel Velasco Suarez Mexico City México
  38. 38Department of Pathology Aga Khan University Hospital Nairobi Kenya
  39. 39Department of Neurology Inha University College of Medicine Incheon Republic of Korea
  40. 40Centre for Healthy Ageing, Health Futures Institute Murdoch University Perth Western Australia Australia

Abstract

INTRODUCTION: Dementia prevention research increasingly uses multimodal interventions. Harmonized biomarker practices are essential to enable comparable cross‐population analysis with initiatives such as the World‐Wide FINGERS (WW‐FINGERS) network contributing to this effort.

METHODS: To advance globally representative biomarker research in dementia prevention trials, we conducted a cross‐sectional, network‐wide survey of WW‐FINGERS teams assessing biospecimen collection, processing and storage, biomarker measurements, and readiness for harmonized procedures.

RESULTS: Most studies (30/39) had or were developing biorepositories; four planned collection and five had none. Practices were broadly aligned, but remaining variability highlights priority targets for harmonization. Clinical biomarkers (lipids, glucose, liver/kidney function) were obtained even in lower‐resourced settings. Many studies measured Alzheimer's disease and related dementias (ADRD) biomarkers (blood‐based amyloid/tau and neurodegeneration; cerebrospinal fluid where feasible) and increasingly used multi‐omics platforms. Evidence‐based preanalytical guidance were provided.

CONCLUSION: The WW‐FINGERS biorepository provides a world‐first platform for harmonized biomarker discovery across diverse populations in dementia prevention, helping to reduce inequities in research participation, accelerating globally representative strategies.

Related

  1. Prevalence of dementia among community-dwelling older adults in rural Uganda: findings from DEPEND Uganda (Dementia Epidemiology, unmet need and co-developing solutions in Uganda)
    J. E. Prynn, R. Alinaitwe, B. Kimono +7
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  2. UK Dementia Trials Network: an expert‐informed framework for improving representation in dementia trials
    Igor C. Fontana, Tara Comber, Sheena Aurora +20
    Alzheimer's & DementiaPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMCEurope PMC
  3. Benchmarking and developing large language models using one million clinical trials
    Zifeng Wang, Jiacheng Lin, Qiao Jin +5
    npj Digital MedicinePeer-reviewedCC BYFull text12 citedEpidemiology & public healthOpenAlex
  4. Blood Biomarkers of Alzheimer's Disease Neuropathology, Cognition, and Response to a Multidomain Lifestyle Intervention: Secondary analysis of the FINGER Randomized Controlled Dementia Risk Reduction Trial
    A. Rosenberg, A. Solomon, A. Matton +13
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
  5. Hydrostatic Reduction of Intussusception under Ultrasound Guidance: An Initial Experience in a Developing Country
    Omolola Mojisola Atalabi, O O Ogundoyin, D I Ogunlana +3
    African Journal of Paediatric SurgeryPeer-reviewedCC BY-NC-SAFull text9 citedSurgery & anaesthesiaOpenAlex
BibTeX
@article{matton2026developing,
  title = {{Developing the World‐Wide FINGERS biorepository for dementia risk reduction trials}},
  author = {Anna Matton and Chinedu Udeh‐Momoh and Makrina Daniilidou and Erika Bereczki and Vilma Alanko and Paola Padilla and Laura D. Baker and Kitti Ban and Miguel G. Borda and Paulo Caramelli and Pablo Martinez‐Lage Alvarez and Marta del Campo and Carlo Ferrarese and Tobias Hartmann and Hamidul Huque and Thomas K. Karikari and Derya Kaya and Rejko Kruger and Yi‐Chun Kuan and Mitchell K. P. Lai and Karen Mather and Emily Meyers and Njideka Okubadejo and Stanley Onyango and Norfadilah Rajab and Maria Vania Rocha da Silva Nunes and Anna Rosenberg and Gessica Sala and Rosa Maria Salinas Contreras and Shahin Sayed and Margaret Scales and Seong Hye Choi and Hamid Sohrabi and Hilkka Soininen and Taiki Sugimoto and Ezequiel Surace and Yongxiang Wang and Henrik Zetterberg and Marissa Zwan and Ari Solomon and Francesca Mangialasche and Miia Kivipelto and the World‐Wide FINGERS network},
  journal = {Alzheimer's \& Dementia},
  year = {2026},
  month = nov,
  doi = {10.1002/alz.71949},
  url = {https://doi.org/10.1002/alz.71949},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Developing the World‐Wide FINGERS biorepository for dementia risk reduction trials
AU  - Anna Matton
AU  - Chinedu Udeh‐Momoh
AU  - Makrina Daniilidou
AU  - Erika Bereczki
AU  - Vilma Alanko
AU  - Paola Padilla
AU  - Laura D. Baker
AU  - Kitti Ban
AU  - Miguel G. Borda
AU  - Paulo Caramelli
AU  - Pablo Martinez‐Lage Alvarez
AU  - Marta del Campo
AU  - Carlo Ferrarese
AU  - Tobias Hartmann
AU  - Hamidul Huque
AU  - Thomas K. Karikari
AU  - Derya Kaya
AU  - Rejko Kruger
AU  - Yi‐Chun Kuan
AU  - Mitchell K. P. Lai
AU  - Karen Mather
AU  - Emily Meyers
AU  - Njideka Okubadejo
AU  - Stanley Onyango
AU  - Norfadilah Rajab
AU  - Maria Vania Rocha da Silva Nunes
AU  - Anna Rosenberg
AU  - Gessica Sala
AU  - Rosa Maria Salinas Contreras
AU  - Shahin Sayed
AU  - Margaret Scales
AU  - Seong Hye Choi
AU  - Hamid Sohrabi
AU  - Hilkka Soininen
AU  - Taiki Sugimoto
AU  - Ezequiel Surace
AU  - Yongxiang Wang
AU  - Henrik Zetterberg
AU  - Marissa Zwan
AU  - Ari Solomon
AU  - Francesca Mangialasche
AU  - Miia Kivipelto
AU  - the World‐Wide FINGERS network
PY  - 2026
DA  - 2026/11/09
JO  - Alzheimer's & Dementia
DO  - 10.1002/alz.71949
UR  - https://doi.org/10.1002/alz.71949
AB  - INTRODUCTION: Dementia prevention research increasingly uses multimodal interventions. Harmonized biomarker practices are essential to enable comparable cross‐population analysis with initiatives such as the World‐Wide FINGERS (WW‐FINGERS) network contributing to this effort.  METHODS: To advance globally representative biomarker research in dementia prevention trials, we conducted a cross‐sectional, network‐wide survey of WW‐FINGERS teams assessing biospecimen collection, processing and storage, biomarker measurements, and readiness for harmonized procedures.  RESULTS: Most studies (30/39) had or were developing biorepositories; four planned collection and five had none. Practices were broadly aligned, but remaining variability highlights priority targets for harmonization. Clinical biomarkers (lipids, glucose, liver/kidney function) were obtained even in lower‐resourced settings. Many studies measured Alzheimer's disease and related dementias (ADRD) biomarkers (blood‐based amyloid/tau and neurodegeneration; cerebrospinal fluid where feasible) and increasingly used multi‐omics platforms. Evidence‐based preanalytical guidance were provided.  CONCLUSION: The WW‐FINGERS biorepository provides a world‐first platform for harmonized biomarker discovery across diverse populations in dementia prevention, helping to reduce inequities in research participation, accelerating globally representative strategies.
SN  - 1552-5260
SN  - 1552-5279
ER  -